HF 3664

  • Minnesota House Bill
  • 2023-2024 Regular Session
  • Introduced in House Feb 13, 2024
  • House
  • Senate
  • Governor

Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.

Votes


No votes to display

Actions


Mar 18, 2024

House

Author added Hemmingsen-Jaeger

Mar 13, 2024

House

Author added Nadeau

Feb 26, 2024

House

Author added Reyer

Feb 13, 2024

House

Introduction and first reading, referred to Health Finance and Policy

Bill Text

Bill Text Versions Format
Introduction PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Minnesota Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.